Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2025-01-22 00:00:00 ET · period of report 2025-01-17 · accession 0000950170-25-007805 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 2025-01-17 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +147.4K | 1.30M | +13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-01-17 | A | A | 147,354 | $0.00 | 1,299,698 | D | — | — | (F2) The reporting person acquired 2,014 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2024. |